Search Results - M. Bonanni

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    P024 | COMBINATION OF BASELINE CA125 LEVELS AND EOT FDG-PET DYNAMICALLY STRATIFIES FAILURE RISK IN PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA TREATED WITH DA-EPOCH-R: A REAL... by A. Fresa, M. Bonanni, A. Cuccaro, F. Ibello, D. Donnarumma, U. Falcone, M. Arcamone, S. Crisci, L. Sirica, M. Esposito, F. Volzone, C. Becchimanzi, S. Mele, R. De Filippi, A. Pinto

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  2. 2

    P020 | EXTENDED LEAD-IN PHASE OF BRENTUXIMAB VEDOTIN AND SHORTENED AVD IN OLDER PATIENTS (>60 YEARS) WITH ADVANCED HODGKIN LYMPHOMA (HL) AND HIGH COMORBIDITY BURDEN (ECOG≥2 AND/... by M. Bonanni, A. Cuccaro *, S. Mele *, E. Morelli, A. Fresa, M. Arcamone, F. Ibello, M. Esposito, M. Saggese, S. Crisci, M. Rivieccio, L. Simeone, F. Volzone, G. Corazzelli, R. De Filippi, A. Pinto

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  3. 3

    P023 | EFFICACY OF BISPECIFIC ANTIBODIES MOSUNETUZUMAB AND GLOFITAMAB IN B-CELL LYMPHOMA CELLS IS NOT AFFECTED BY THE RESISTANCE TO RITUXIMAB, OBINUTUZUMAB AND POLATUZUMAB. by S. Mele, S. Crisci, D. Galati, A. Fresa, A. Cuccaro, M. Bonanni, P. Maiolino, R. Azzaro, M. Saggese, M. Oro, S. Sarno, A. Altobelli, D. Donnarumma, F. Volzone, G. Marcacci, D. Mallardo, A. Pinto, R. De Filippi

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  4. 4

    P158 | DARATUMUMAB, LENALIDOMIDE AND DEXAMETHASONE IN NEWLY-DIAGNOSED MULTIPLE MYELOMA PATIENTS AGED ≥80 YEARS: A MULTICENTER RETROSPECTIVE ANALYSIS OF EFFICACY AND TOLERABILITY FR... by S. Palmieri, R. Della Pepa, S. Rocco, D. De Novellis, G. Marcacci, G. Cetani, V. Amico, M. Barone, R. Bianco, D. Esposito, M. Raimondo, A. Leone, M. Fevola, N. Pugliese, R. Fontana, M. Rizzo, M. Bonanni, M. Arcamone, C. Masucci, G.R. Nunziata, A.M. Risitano, C. Califano, G. Cerciello, F. Frigeri, A. Pinto, C. Selleri, F. Pane

    Published in Haematologica (2025-09-01)
    Get full text
    Article


  5. 5

    P167 | OUTCOMES OF SECOND-LINE THERAPY IN FUNCTIONAL HIGH-RISK MULTIPLE MYELOMA AFTER DARATUMUMAB-BASED INDUCTION: AN ITALIAN REAL-WORLD STUDY by S. Palmieri, S. Rocco, R. Della Pepa, D. Derudas, D. Roccotelli, D. Esposito, C. Masucci, E. Gigliotta, M.L. Barone, E. Morelli, A. Lazzaro, G. Cetani, F. Accardi, M. Bonanni, A.M. Della Corte, B. Serio, E. Urciuoli, R. Bianco, M. Rizzo, R. Fontana, M. Arcamone, R. Iula, A. Dandolo, A. Leone, M.G. Rascato, M. Di Perna, A.P. Falcone, L. Morello, G. Marcacci, G.R. Nunziata, F. Frigeri, C. Califano, A.M. Carella, A.M. Risitano, M. Annunziata, F. Pane, C. Botta

    Published in Haematologica (2025-09-01)
    Get full text
    Article


Search Tools: